about
Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validationMononuclear phagocytes and airway epithelial cells: novel sources of matrix metalloproteinase-8 (MMP-8) in patients with idiopathic pulmonary fibrosis.CCN1 secretion and cleavage regulate the lung epithelial cell functions after cigarette smoke.Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosisGenetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responsesA YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditionsSyndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.Transforming growth factor-β1 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway.Impact of human leukocyte antigen molecules E, F, and G on the outcome of transplantation.Diabetes mellitus and renal transplantation in adults: is there enough evidence for diagnosis, treatment, and prevention of new-onset diabetes after renal transplantation?Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer.Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.Optimizing Treatment Approaches in Advanced Renal Cancer.Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.Twist on a classic: vitamin D and hypercalcaemia of malignancy.Beclin-1 regulates cigarette smoke-induced kidney injury in a murine model of chronic obstructive pulmonary diseaseUnderstanding and quantifying the immune microenvironment in hepatocellular carcinomaSignificance of cytomegalovirus prophylaxis strategies and development of cancer in kidney transplant recipientsRituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case ReviewLung Adenocarcinoma Syndecan-2 Potentiates Cell InvasivenessLesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade
P50
Q28660920-C7CFF626-0363-48BE-84C1-8DD7549BC6C4Q33610227-41539110-5644-4828-85E7-BAD0DE1B29B7Q34062984-76E51F51-5230-4BC6-856C-C63CE38A3AECQ34408059-AC670150-C3C7-497B-B997-8D0269129340Q35580488-57AAD64F-E703-4A8F-9A35-CA1389357FEFQ35695350-E46B1AC9-A003-4BD7-9616-DE33C8282DDCQ35766847-BB824E09-77F9-4A4B-8761-36E7085EC83CQ36238774-0639B055-43C3-42C6-9DBC-3D2E84230674Q36370996-EA86FA71-19EF-4CE5-BF25-603641A114D2Q37304340-2DC668D9-4F73-4D58-B77D-527809AE0164Q37649952-902EA6CC-3D63-4CDC-845A-1FB421A27ECBQ38270952-3C2A7032-DFB0-48D4-8504-D27E6C62DBF2Q38270956-5AC008BC-2C4A-47E2-B281-889FE26D2B64Q40414975-F274B72E-2E5B-42BC-8F2F-CD1D7FE06B96Q46573013-B9DB84CC-4227-48A1-8302-00DC1DAF4E9DQ47216156-E6F0BAC8-35A0-4041-9A8B-A6E249DEDC0DQ47262049-9C947072-874B-440B-A353-D3031C2B446EQ47369763-93CF5E8B-76B3-46A7-808A-96AF44DAC537Q59125556-60CB7F50-9A02-4B1E-A5BD-DC6C2A68AF05Q61455274-07E889B1-BD45-4976-8357-81CDEF175AF7Q82591532-BB58C424-AB64-4916-B94B-F48A0213DE43Q88239776-85BC6DE8-BAC4-409C-ADB4-1203B5943109Q90612994-3B14FD56-BD67-4E5A-A62E-D4868C3BCDF3Q91055476-B8C1D2E4-65A3-468E-8913-8DDC0855DB92
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Juan C Osorio
@ast
Juan C Osorio
@en
Juan C Osorio
@es
Juan C Osorio
@nl
Juan C Osorio
@sl
type
label
Juan C Osorio
@ast
Juan C Osorio
@en
Juan C Osorio
@es
Juan C Osorio
@nl
Juan C Osorio
@sl
altLabel
Juan C. Osorio
@en
prefLabel
Juan C Osorio
@ast
Juan C Osorio
@en
Juan C Osorio
@es
Juan C Osorio
@nl
Juan C Osorio
@sl
P106
P21
P31
P496
0000-0001-8090-1551